Aqemia, a Parisian deep tech startup, has raised €1 million pre-seed round from Elaia to develop its molecule matching technology. The company aims to transform pharmaceutical research and disrupt the $60 billion drug discovery market. Aqemia’s core software, developed from academic research at École normale supérieure (PSL), can predict the effectiveness of a pharmaceutical drug. […]
Cambridge-based Healx, an AI-powered biotech company researching treatments for rare diseases, has raised a $56 million Series B led by Atomico, joined by Intel Capital, Global Brain and btov Partners. The investment enables the company to launch its global Rare Treatment Accelerator programme, as well as pursue ongoing research. Healx is innovating on the traditional […]
Last week, I hopped on a call with Emil Hewage, the affable co-founder and CEO of a Cambridge-based company called BIOS, in an effort to understand what the ‘neural engineering startup’ is up to – with limited success at first, I might add. Indeed, BIOS’ mission (to create “the open standard hardware and software interface […]
Acacia Pharma, which is developing treatments for surgical and cancer patients, this month listed on Euronext stock exchange in Brussels, raising €40 million.
Nuritas, an Irish biotech startup, has raised €16 million in a Series A round led by US firm Cultivian Sandbox Ventures. Nuritas has built a medical platform that uses artificial intelligence to analyse peptides in food, which it claims is 500 times faster than current technology. “Our artificial intelligence platform has already disrupted this antiquated […]
Eligo Bioscience, a biotech company based in France, has raised a $20 million Series A round from Khosla Ventures and Seventure Partners together with a $2 million award from Worldwide Innovation Challenge. Eligo is developing a biotherapeutic platform – dubbed the eligobiotics platform – that uses nanobots to engineer microbiomes in the development of precision […]
Labiotech.eu, a biotech news resource based in Berlin has secured a funding round from Swiss firm Wille AG, Indiana Capital, JOT-Berlin, and Iduskia alongside a number of previous investors. The investment figure has not been disclosed. The biotech news site and event organiser’s “six-figure seed round” follows a similar investment from last year, which will […]